Seneviratne Sanjeewa, Lawrenson Ross, Harvey Vernon, Ramsaroop Reena, Elwood Mark, Scott Nina, Sarfati Diana, Campbell Ian
Waikato Clinical School, University of Auckland, Hamilton, New Zealand.
Department of Surgery, University of Colombo, Colombo, Sri Lanka.
BMC Cancer. 2016 Feb 19;16:129. doi: 10.1186/s12885-016-2177-5.
Examination of factors associated with late stage diagnosis of breast cancer is useful to identify areas which are amenable to intervention. This study analyses trends in cancer stage at diagnosis and impact of socio-demographic, cancer biological and screening characteristics on cancer stage in a population-based series of women with invasive breast cancer in New Zealand.
All women diagnosed with invasive breast cancer between 2000 and 2013 were identified from two regional breast cancer registries. Factors associated with advanced (stages III and IV) and metastatic (stage IV) cancer at diagnosis were analysed in univariate and multivariate models adjusting for covariates.
Of the 12390 women included in this study 2448 (19.7%) were advanced and 575 (4.6%) were metastatic at diagnosis. Māori (OR = 1.86, 1.39-2.49) and Pacific (OR = 2.81, 2.03-3.87) compared with NZ European ethnicity, other urban (OR = 2.00, 1.37-2.92) compared with main urban residency and non-screen (OR = 6.03, 4.41-8.24) compared with screen detection were significantly associated with metastatic cancer at diagnosis in multivariate analysis. A steady increase in the rate of metastatic cancer was seen which has increased from 3.8% during 2000-2003 to 5.0% during 2010-2013 period (p = 0.042).
Providing equitable high quality primary care and increasing mammographic screening coverage needs to be looked at as possible avenues to reduce late-stage cancer at diagnosis and to reduce ethnic, socioeconomic and geographical disparities in stage of breast cancer at diagnosis in New Zealand.
研究与乳腺癌晚期诊断相关的因素,有助于确定可进行干预的领域。本研究分析了新西兰一系列基于人群的浸润性乳腺癌女性患者的癌症诊断分期趋势,以及社会人口统计学、癌症生物学和筛查特征对癌症分期的影响。
从两个地区乳腺癌登记处识别出2000年至2013年间所有诊断为浸润性乳腺癌的女性。在单变量和多变量模型中分析诊断时与晚期(III期和IV期)和转移性(IV期)癌症相关的因素,并对协变量进行调整。
本研究纳入的12390名女性中,2448名(19.7%)诊断时为晚期,575名(4.6%)诊断时为转移性。多变量分析显示,与新西兰欧洲族裔相比,毛利族(比值比=1.86,1.39 - 2.49)和太平洋族裔(比值比=2.81,2.03 - 3.87);与主要城市居住相比,其他城市(比值比=2.00,1.37 - 2.92);与筛查发现相比,未筛查(比值比=6.03,4.41 - 8.24)在诊断时与转移性癌症显著相关。转移性癌症发生率呈稳步上升趋势,从2000 - 2003年的3.8%增至2010 - 2013年的5.0%(p = 0.042)。
提供公平的高质量初级保健服务以及提高乳房X光筛查覆盖率,有望成为减少诊断时晚期癌症的途径,并缩小新西兰乳腺癌诊断分期中的种族、社会经济和地域差异。